America Stem Cell, Inc. Company Profile

02:25 EST 29th November 2014 | BioPortfolio

America Stem Cell is a privately held biotechnology company based in San Antonio, TX, with offices in San Diego, CA, and is dedicated to the development and commercialization of stem cell enabling technologies/products to transform clinical outcomes for patients undergoing stem cell transplantation. The key stem cell enabling platform technologies/compounds (ASC-101 and ASC-201) designed to improve the homing and engraftment of stem cells to target organs and increase their therapeutic potential for patients in need of stem cell transplantation. Additionally, these platforms have the potential to enhance stem cell treatment of inflammation from chemotherapy/radiation, solid tumors, autoimmune diseases, and ischemic diseases including myocardial infarction and stroke. America Stem Cell has strategic partnerships with medical research institutions including The University of Texas M.D. Anderson Cancer Center, Oklahoma Medical Research Foundation, National Institute of Health, Fred Hutchinson Cancer Center, University of California San Diego, the Sanford-Burnham Institute, Indiana University, Juvenile Diabetes Research Foundation, as well as corporate partnerships. For additional information, please contact Lynnet Koh at 210-410-6427 or view http://www.americastemcell.com.


News Articles [3347 Associated News Articles listed on BioPortfolio]

Neural stem cell quiescence comes to an un-sticky end

Cell–cell interactions, a key feature of the stem cell niche, regulate many aspects of stem cell behaviour. N-cadherin-mediated anchorage of neural stem cells within the adult neural niche maintains...

Marius Wernig receives New York Stem Cell Foundation's Robertson Stem Cell Prize

(New York Stem Cell Foundation) The New York Stem Cell Foundation announced today that Marius Wernig, PhD, Associate Professor in the Institute for Stem Cell Biology and Regenerative Medicine and the ...

Mechanism that allows differentiated cell to reactivate as a stem cell revealed

A study, performed with fruit flies, describes a gene that determines whether a specialized cell conserves the capacity to become a stem cell again. Unveiling the genetic traits that favor the retenti...

The New York Stem Cell Foundation Research Institute announces largest-ever stem cell repository

(New York Stem Cell Foundation) The New York Stem Cell Foundation Research Institute, through the launch of its repository in 2015, will provide for the first time the largest-ever number of stem cell...

International Stem Cell Corp. Gets FDA Clearance

International Stem Cell Corp., a Carlsbad-based biotech company developing stem cell therapies and biomedical products, announced that the U. S. Food and Drug Administration has cleared the company’...

Stem Cell Tranplants May Help Reduce Seizures, Study Says

(Fox News) – New research from McLean Hospital and the Harvard Stem Cell Institute has shown that stem cell therapy reduces seizures in mice. Researchers used an animal model to transplant seizu...

Stem cell and clinical research advances to be presented at NYSCF's Ninth Annual Conference

(New York Stem Cell Foundation) Leaders in translational stem cell research from around the world will present the latest advances in stem cell science that are leading to better treatments and cures ...

One Japan Stem Cell Institute Soars, One Struggles

As Nobel Prize-winning scientist Shinya Yamanaka regaled a New York crowd with advances that may send his Japanese institute to the top of the global stem cell field, investigators in Tokyo said the s...

PubMed Articles [6395 Associated PubMed Articles listed on BioPortfolio]

Stem Cell Tourism and Public Education: The Missing Elements.

Stem cell tourism describes the Internet-based industry where in patients receive unproven stem cell interventions. To better inform the public, several organizations provide educational material on s...

YY1 is indispensable for Lgr5+ intestinal stem cell renewal.

The intestinal stem cell fuels the highest rate of tissue turnover in the body and has been implicated in intestinal disease and cancer; understanding the regulatory mechanisms controlling intestinal ...

Stem Cell-Based Therapies for Ischemic Stroke.

In recent years, stem cell-based approaches have attracted more attention from scientists and clinicians due to their possible therapeutical effect on stroke. Animal studies have demonstrated that the...

Day-night cycles and the sleep-promoting factor, Sleepless, affect stem cell activity in the Drosophila testis.

Adult stem cells maintain tissue integrity and function by renewing cellular content of the organism through regulated mitotic divisions. Previous studies showed that stem cell activity is affected by...

MDS Is a Stem Cell Disorder After All.

Myelodysplastic syndrome (MDS) has long been presumed to be a stem cell disorder, but rigorous formal proof has been lacking. In this issue of Cancer Cell, Woll and colleagues demonstrate that driver ...

Clinical Trials [3976 Associated Clinical Trials listed on BioPortfolio]

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

RATIONALE: It is not yet known which method of stem cell collection is best for patients undergoing an autologous stem cell transplant. PURPOSE: This randomized phase III trial is compari...

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune ...

Stem Cell Transplantation for Patients With Multiple Myeloma

The purpose of this study is to test whether regulatory T-cell reduction is possible and safe in myeloma subjects undergoing autologous stem cell transplantation (ASCT).

Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders

This study performs HLA matched stem cell transplantation from unrelated donors in adults who require stem cell transplantation but do not have a matched related donor available. The incid...

Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency

The purpose of this study is to determine whether cultivated stem cell transplantation is effective for the treatment of patients wtih corneal stem cell deficiency.

Companies [1738 Associated Companies listed on BioPortfolio]

America Stem Cell, Inc.

America Stem Cell is a privately held biotechnology company based in San Antonio, TX, with offices in San Diego, CA, and is dedicated to the development and commercialization of s...

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers ge...

Cord Blood America, Inc.

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected ste...

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

More Information about "America Stem Cell, Inc." on BioPortfolio

We have published hundreds of America Stem Cell, Inc. news stories on BioPortfolio along with dozens of America Stem Cell, Inc. Clinical Trials and PubMed Articles about America Stem Cell, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of America Stem Cell, Inc. Companies in our database. You can also find out about relevant America Stem Cell, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Transplantation
Latest News Clinical Trials Research Drugs Reports Corporate
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record